These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37961028)

  • 1. Recent Advances in RNA-Targeted Cancer Therapy.
    Li M; Zhu J; Lv Z; Qin H; Wang X; Shi H
    Chembiochem; 2024 Feb; 25(4):e202300633. PubMed ID: 37961028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD; Huang L
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy.
    Lee JW; Choi J; Choi Y; Kim K; Yang Y; Kim SH; Yoon HY; Kwon IC
    J Control Release; 2022 Nov; 351():713-726. PubMed ID: 36152808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
    Sivakumar P; Kim S; Kang HC; Shim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi-based therapeutics and tumor targeted delivery in cancer.
    Kara G; Calin GA; Ozpolat B
    Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics.
    Akhtari J; Tafazoli A; Mehrad-Majd H; Mahrooz A
    Curr Clin Pharmacol; 2018; 13(3):173-182. PubMed ID: 29992895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in siRNA delivery in cancer therapy.
    Singh A; Trivedi P; Jain NK
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):274-283. PubMed ID: 28423924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy.
    Zhang J; Chen B; Gan C; Sun H; Zhang J; Feng L
    Int J Nanomedicine; 2023; 18():7605-7635. PubMed ID: 38106451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery.
    Hashemi M; Aparviz R; Beickzade M; Paskeh MDA; Kheirabad SK; Koohpar ZK; Moravej A; Dehghani H; Saebfar H; Zandieh MA; Salimimoghadam S; Rashidi M; Taheriazam A; Entezari M; Samarghandian S
    Biomed Pharmacother; 2023 Dec; 169():115927. PubMed ID: 38006616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of small interfering RNAs by nanovesicles for cancer therapy.
    Pengnam S; Plianwong S; Yingyongnarongkul BE; Patrojanasophon P; Opanasopit P
    Drug Metab Pharmacokinet; 2022 Feb; 42():100425. PubMed ID: 34954489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipidic systems for in vivo siRNA delivery.
    Wu SY; McMillan NA
    AAPS J; 2009 Dec; 11(4):639-52. PubMed ID: 19757082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic siRNA: principles, challenges, and strategies.
    Gavrilov K; Saltzman WM
    Yale J Biol Med; 2012 Jun; 85(2):187-200. PubMed ID: 22737048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA delivery systems for cancer treatment.
    Oh YK; Park TG
    Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
    Hong CA; Nam YS
    Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in siRNA Modification and Ligand Conjugated Delivery To Enhance RNA Interference Ability.
    Maguregui A; Abe H
    Chembiochem; 2020 Jul; 21(13):1808-1815. PubMed ID: 32181563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of short interfering RNAs--strategies for in vivo delivery.
    Wullner U; Neef I; Tur MK; Barth S
    Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):1-8. PubMed ID: 19149683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
    De Paula D; Bentley MV; Mahato RI
    RNA; 2007 Apr; 13(4):431-56. PubMed ID: 17329355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design and exogenous delivery of siRNA for post-transcriptional gene silencing.
    Gilmore IR; Fox SP; Hollins AJ; Sohail M; Akhtar S
    J Drug Target; 2004 Jul; 12(6):315-40. PubMed ID: 15545082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
    Revia RA; Stephen ZR; Zhang M
    Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate Receptor-Mediated siRNA Delivery: Recent Developments and Future Directions for RNAi Therapeutics.
    Gangopadhyay S; Nikam RR; Gore KR
    Nucleic Acid Ther; 2021 Aug; 31(4):245-270. PubMed ID: 33595381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.